Phillips-Medisize Gains Rights to Mini-Tablet Dispenser
The company will hold exclusive ownership of patents supporting a mini-tablet dispenser to accommodate the oral dispensing needs of patients.
Phillips-Medisize, a Molex company, announced it is entering into an agreement with an undisclosed global pharmaceutical company for exclusive ownership of patents supporting a mini-tablet dispenser to accommodate the oral dispensing needs of patients.
With this dispenser, a patient or caregiver will be able to count and dispense mini tablets in predetermined amounts from one to 20 tablets, and it supports tablets of approximately 2x2 mm to 2.3x2.3 mm dimensions, according to a Sept. 10, 2019 press release. The device also lets the user visually confirm the measured tablet count number before dispensing and is designed to minimize damage or crushing of the mini tablets during dispensing.
“Through its unique working principle, the mini-tablet dispenser will be valuable in pediatrics, geriatrics, and oncology where patients often require highly flexible oral dosing based on age, weight, and other variables,” said Matt Jennings, CEO and president, Phillips-Medisize, in the press release. “Furthermore, in smaller patient populations the option to flexibly count to combine incremental mini-tablet doses offers an advantage over preparing multiple fixed oral tablet dose strengths.”
The company plans to make the dispenser available to the pharmaceutical market in early 2020.
Source: Phillips-Medisize
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
